---
title: SSO Spotlight Presentation | Perimeter Medical Imaging AI
description: Join us for an educational session on the intraoperative use of Perimeter’s groundbreaking margin visualization technology using Optical Coherence Tomography (OCT).
---

![logo](https://oct.perimetermed.com/hs-fs/hubfs/Landing%20page%202022/logo.png?width=250&height=55&name=logo.png)

![SSO 2022 Logo Color with dates](https://oct.perimetermed.com/hs-fs/hubfs/SSO%202022%20Logo%20Color%20with%20dates.jpg?width=250&height=109&name=SSO%202022%20Logo%20Color%20with%20dates.jpg)

[Schedule a Demo](https://share.hsforms.com/1bN3Uxxb9TqSfTJTFB0P32Q53ca3)

**SPOTLIGHT PRESENTATION**

# A New Paradigm for Intraoperative Margin Visualization with OCT + Future AI

**When**: Friday, March 11 — 12 p.m. - 12:15 p.m.

**Where**: HUB Theater, Hilton Anatole Hotel, Dallas, TX 

Featuring

![Beth DuPree, MD](https://oct.perimetermed.com/hubfs/Permeter_medical/Beth%20DuPree%2c%20MD.svg)

**Beth DuPree, MD**

Breast Surgeon and Clinical Investigator, Sedona, AZ  

![Tower-headshot](https://oct.perimetermed.com/hubfs/Tower-headshot.png)

**Amelia Tower, DO**

Surgeon and OCT User, Texas Health Breast Specialists, Fort Worth, TX

Let us know you're coming

### Join us for an educational session on the intraoperative use of Perimeter’s groundbreaking margin visualization technology powered by Optical Coherence Tomography (OCT), bringing clarity to margin status at the point of care.

##### **The presentation will cover:**

- - Technology behind Perimeter’s S-Series OCT device, delivering high-resolution specimen imaging for intraoperative margin visualization
- Lumpectomy case reviews, including recognizing suspicious tissues and OCT correlation with pathology
- Integrating OCT into your OR workflow
- Future AI\* capabilities undergoing clinical investigation

![IMG_6587_edit](https://oct.perimetermed.com/hubfs/IMG_6587_edit.png)

\**Perimeter is currently conducting a randomized control trial to assess its B-Series OCT imaging platform combined with AI technology on the impact of positive margin rates during breast conservation surgery. Perimeter B-Series OCT with ImgAssist AI is not available for sale in the United States.* *CAUTION: Investigational Device. Limited by U.S. law to investigational use.* *Perimeter’s S-Series OCT is cleared by the FDA and available for sale in the U.S.*

### Connect with Perimeter at SSO 2022

Stop by our kiosk for an interactive demo of Perimeter's new S-Series OCT technology, giving surgeons added clarity with real-time margin visualization in the OR.

[Schedule a Demo](https://share.hsforms.com/1bN3Uxxb9TqSfTJTFB0P32Q53ca3)

REGULAR HUB HOURS: 

Thursday, March 10 — 9 a.m. - 7 p.m.

Friday, March 11 — 9:30 a.m. - 4:45 p.m.

 

The Claire OCT System is an adjunctive three-dimensional imaging tool which provides volumetric cross-sectional, real-time depth visualization, coupled with an artificial intelligence   
computer aided detection algorithm which identifies and marks focal areas suspicious for breast cancer and is used concurrently with physician interpretation of the images.  
The Claire OCT System is intended for use in conjunction with other standard methods for evaluation of the margins of excised lumpectomy tissue during surgical procedures in patients with a biopsy-confirmed diagnosis of breast cancer.

The Claire OCT System is an adjunctive tool; it does not replace standard tissue histopathology nor provide a diagnosis.

©2026 Perimeter Medical Imaging Al. All Rights Reserved.